Immediate Impact

62 standout
Sub-graph 1 of 22

Citing Papers

Advancements and limitations in traditional anti-cancer therapies: a comprehensive review of surgery, chemotherapy, radiation therapy, and hormonal therapy
2025 Standout
Time Trends and Variation in the Use of Active Surveillance for Management of Low-risk Prostate Cancer in the US
2023 Standout
2 intermediate papers

Works of Kevin Blas being referenced

Cost-effectiveness of prostate boost with high-dose-rate brachytherapy versus intensity-modulated radiation therapy in the treatment of intermediate-high risk prostate cancer
2018
The Cancer of the Prostate Risk Assessment (CAPRA) in patients treated with external beam radiation therapy: Evaluation and optimization in patients at higher risk of relapse
2011

Author Peers

Author Last Decade Papers Cites
Kevin Blas 328 123 79 24 396
Bagshaw Ma 268 78 101 22 400
A. Álvarez 318 99 71 26 382
Toru Nishiyama 237 107 159 40 456
Steven Stokes 184 76 82 15 454
Karel A. Hinnen 347 147 77 25 453
M. Santoro 349 272 65 13 424
Eyad Abu‐Isa 200 76 125 23 395
Willis J. Taylor 281 44 131 14 385
Norihisa Katayama 240 119 68 36 394
Jean-Philippe Wagner 213 56 88 13 439

All Works

Loading papers...

Rankless by CCL
2026